{"pageContent": "Purpose: High-dose-rate (HDR) brachytherapy alone is an effective treatment option for patients with early-stage prostate cancer. The purpose of this study was to quantify patient-reported short- and long-term toxicity and quality of life (QOL) after HDR monotherapy.", "metaData": {"source": "Impact of age on quality-of-life outcomes after treatment for localized prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/25656807/"}}